NexGel Inc – Filings and Transcripts

NASDAQ: NXGL
Share price (6/2/26): $0.58
Market cap (6/2/26): $5.305 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Henry Scott Robert

Kieser Brian Joseph

News Filter

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Appoints Brian Kieser and Kevin Harris From New Strategic Partner, Sequence LifeScience™, to Board of Directors

Appoints Ian Blackman as Chief Financial Officer

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

New Strategic Partner, Sequence LifeScience™, Leads Financing With $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment

Proxies Filter

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC